92 related articles for article (PubMed ID: 11699207)
1. Over-expression of the functional interleukin-11 alpha receptor in the development of B-cell chronic lymphocytic leukemia.
Tsimanis A; Shvidel L; Klepfish A; Shtalrid M; Kalinkovich A; Berrebi A
Leuk Lymphoma; 2001 Jun; 42(1-2):195-205. PubMed ID: 11699207
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes.
Airoldi I; Raffaghello L; Cocco C; Guglielmino R; Roncella S; Fedeli F; Gambini C; Pistoia V
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):144-54. PubMed ID: 14734463
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant human interleukin-11 on expressions of interleukin-11 receptor alpha-chain and glycoprotein 130 in intestinal epithelium cell line-6 after neutron irradiation.
Wang RJ; Peng RY; Fu KF; Gao YB; Han RG; Hu WH; Luo QL; Ma JJ
World J Gastroenterol; 2006 May; 12(19):3055-9. PubMed ID: 16718787
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients.
Manouchehri-Doulabi E; Abbaspour S; Rostami S; Faranoush M; Ghahramanfard F; Pak F; Barati M; Kokhaei P; Momtazi-Borojeni AA
J Cell Physiol; 2020 Dec; 235(12):9424-9431. PubMed ID: 32383245
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
[TBL] [Abstract][Full Text] [Related]
11. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
[TBL] [Abstract][Full Text] [Related]
12. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11.
Schwertschlag US; Trepicchio WL; Dykstra KH; Keith JC; Turner KJ; Dorner AJ
Leukemia; 1999 Sep; 13(9):1307-15. PubMed ID: 10482979
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
15. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
16. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
17. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
19. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.
Sainz-Perez A; Gary-Gouy H; Portier A; Davi F; Merle-Beral H; Galanaud P; Dalloul A
Leukemia; 2006 Mar; 20(3):498-504. PubMed ID: 16408101
[TBL] [Abstract][Full Text] [Related]
20. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
